FDA Clearance Tracker · P150031-S003
Vercise DBS System
Last checked: Nov 20, 2026Latest source record: Apr 24, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Apr 24, 2018
Approved
Time to decision
97 days
Received Jan 17, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P150031-S003
- Device name
- Vercise DBS System
- Applicant
- Boston Scientific Corp
- Applicant location
- Valencia, CA
- Received
- Jan 17, 2018
- Decided
- Apr 24, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P150031
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for manufacturing sites located at Boston Scientific Limited, Cashel Road, Clonmel, Ireland (Vercise DBS IPG packaging, sterilization, and distribution operations); Guidant Puerto Rico B.V., No. 12, Road 698, Dorado, Puerto Rico (Vercise Leads, Extension, M8 Adaptor, and Physicians Spare Kit manufacturing and sterilization operations); and Boston Scientific Corporation, 4100 Hamline Avenue North, St. Paul, Minnesota (Vercise external devices and surgical accessories manufacturing and sterilization operations).
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.